AlphaYou
Overview
Key stats
Fundamentals Sep 9- Open
- $19.47
- 52-wk high
- $24.27
- High
- $19.74
- 52-wk low
- $9.54
- Low
- $18.04
- Prev close
- $19.71
- Mkt cap
- $1.06B
- Volume
- 725.7K
- Beta
- 0.79
- P/S
- 17916.0x
- P/B
- 2.3x
- Profit margin
- +0.0%
- Op margin
- -154847.0%
- ROE
- -36.3%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 25.8% below what analysts expected.
Earnings per share
-$0.66 expected
What the street expects next
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $0 | $59.0K | $0 | $0 |
| Cost of what it sold | $10.0M | $16.0K | $17.0K | — |
| Gross profit | -$10.0M | $59.0K | -$17.0K | — |
| What it spent | ||||
| Research and development | $13.6M | $13.3M | $14.0M | $23.4M |
| Sales and admin | $5.6M | $6.2M | $6.8M | $8.0M |
| Other operating costs | -$10.0M | $381.0K | — | — |
| Total operating expenses | $9.2M | $19.8M | $20.9M | $31.5M |
| What was left | ||||
| Operating profit | -$19.2M | -$19.7M | -$20.9M | -$31.5M |
| Profit before tax | -$30.6M | -$13.6M | -$19.6M | -$36.3M |
| Tax | $11.0K | $130.0K | $12.0K | $18.0K |
| Net profit | -$30.6M | -$13.7M | -$19.6M | -$36.4M |
| EBITDA | -$30.6M | -$13.6M | -$19.6M | -$36.3M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bearish
Tone of tracked coverage
Avalo Therapeutics CMO Mittie Doyle sells $20,000 in stock
Leans bearishSep 3Avalo Therapeutics CFO Sullivan sells over $1.4m in stock By Investing.com
Leans bearishSep 3Avalo Therapeutics chief medical officer Mittie Doyle sells $20,000 shares
NeutralAug 26Avalo Therapeutics CFO sells over $1.45 million in stock By Investing.com
Leans bearishAug 25Avalo Therapeutics CFO sells over $1.45 million in stock
Leans bearishAug 25
Macro
10 macro signals shaping AVTX right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results